Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com.
View Top Employees from ObsEva SA| Website | http://www.obseva.com |
| Ticker | OBSV |
| Revenue | $408000 |
| Funding | $96.8 million |
| Employees | 44 (44 on RocketReach) |
| Founded | 2012 |
| Address | 12 Chemin Des Aulx, Plan-les-Ouates, Geneva 1228, CH |
| Phone | +41 22 552 38 40 |
| Technologies |
JavaScript,
HTML,
Twitter
+14 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Pharmaceutical, Health Care, Therapeutics, Women's |
| Web Rank | 8 Million |
| Keywords | Obseva, Lizagolix, Linzagolix |
| Competitors | Destiny Pharma plc, Entera Bio Ltd., Gedeon Richter - PregLem S.A., Soligenix, Inc., iTeos Therapeutics |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular ObsEva SA employee's phone or email?
ObsEva SA Questions
The ObsEva SA annual revenue was $408000 in 2024.
Ben Tan is the Vice President Commercial and Business Development of ObsEva SA.
44 people are employed at ObsEva SA.
ObsEva SA is based in Plan-les-Ouates, Geneva.
The NAICS codes for ObsEva SA are [32541, 3254, 32, 325].
The SIC codes for ObsEva SA are [28, 283].
Top ObsEva SA Employees
-
22
-
ViewBen Tan
Vice President Commercial and Business Development at ObsEva SA
Basel, Basel-City, Switzerland3 -
3
-
42
-
45+
Related Companies
